drugset / Trial / NCT04445363
A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata
RandomizedParallel-groupDouble-blindTreatment
Summary
This study includes a dose escalation part(phase I) and a dose extension part(phase II).
Timeline
- Start
- 2020-08-12
- Primary completion
- 2024-12-01
- Completion
- 2024-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Jaktinib | Unknown | 0.5 % | Topical |
| Subject | Jaktinib | Unknown | 1.5 % | Topical |
| Subject | Jaktinib | Unknown | 2.5 % | Topical |